Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
2 意见
• 07/29/23
0
0
嵌入
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论